SXL
ARMP icon

Summit X LLC’s Armata Pharmaceuticals ARMP Stock Holding History

Summit X LLC’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,057
Closed -$18K – 239
2019
Q1 		$18K Hold
4,057
– – 0.01% 237
2018
Q4 		$11K Buy
4,057
+1,964
+94% +$9.58K 0.01% 202
2018
Q3 		$30K Hold
2,093
– – 0.01% 221
2018
Q2 		$33K Buy
2,093
+664
+46% +$10.8K 0.02% 204
2018
Q1 		$22K Buy
1,429
+72
+5% +$1.28K 0.01% 181
2017
Q4 		$19K Buy
1,357
+428
+46% +$6.32K 0.01% 175
2017
Q3 		$12K Buy
+929
New +$11.9K 0.01% 177

Other funds holding ARMP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit X LLC's ARMP Position: Q2 2019 in Review

Summit X LLC sold out of Armata Pharmaceuticals (ARMP) in Q2 2019, closing a stake of 4,057 shares — an estimated $18K sold.

Summit X LLC first reported a position in ARMP in Q3 2017 and held it in 7 quarters. The position peaked at $33K in Q2 2018. 12 funds tracked by Wall St. Rank hold ARMP as of Q2 2019.

  • Summit X LLC reported no remaining Armata Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Summit X LLC sold 4,057 Armata Pharmaceuticals shares in Q2 2019, an estimated $18K.
  • Summit X LLC first reported a position in Armata Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Summit X LLC's Armata Pharmaceuticals position peaked at $33K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2019.

Based on Summit X LLC's 13F filing for Q2 2019, filed 13 Aug 2019.